ArticleScientific reports2020

Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.

Ryota Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.